TRIM72 and diabetes mellitus: In our study, we aimed to examine whether there is a difference in serum MG53 levels between the patient group diagnosed with type 2 DM and the healthy control group without metabolic syndrome and diabetes and to determine the relationship between diabetic complications and glycemic control and MG53 levels in the patient group.